AROG Pharmaceuticals, Inc.
- Biotech or pharma, therapeutic R&D
Arog is a late-stage, privately held U.S. biopharmaceutical company enrolling pivotal studies for crenolanib, an oral TKI with best-in-class profile for FLT3-mutated AML. Preliminary clinical data in solid tumors (gastric cancer, glioma, sarcoma, and lung cancer) have also been generated.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}